Resources with keywords: wastewater
GVN assessment (3 Apr 2026) concludes BA.3.2 shows antibody escape but no evidence of increased severity or aerosol-generating transmissibility beyond known Omicron characteristics. Standard clinical laboratory biosafety (BSL-2) remains appropriate for routine SARS-CoV-2 specimen processing. Facilities should continue wastewater surveillance as an early-warning tool for variant emergence that could affect HCW exposure levels.
Wastewater surveillance testing for measles can alert public health authorities to possible local measles transmission before and during a measles outbreak and help guide public health preparedness and response.
During a June 11–September 26, 2024, measles outbreak in Oregon, a retrospective analysis of archived regional wastewater data collected during March 24–September 22, 2024, detected wild-type measles virus in 20 of 94 (21.3%) samples. The first detection of measles virus in wastewater was in a sample collected on April 3, 2024, which preceded the first confirmed measles case by 10 weeks.
Genomic analysis and wastewater testing can complement traditional case-based surveillance to identify and better characterize HAV outbreaks.
Between September and December 2024, four countries in the EU/EEA (Finland, Germany, Poland, Spain) and the United Kingdom reported detections of circulating vaccine-derived poliovirus type 2 (cVDPV2) in sewage samples. This is the first time cVDPV2 has been detected in EU/EEA countries from environmental surveillance.
EID Whitehouse ER, Gerloff N, English R, Reckling SK, Alazawi MA, Fuschino M, et al.
Yinda C, Morris DH, Fischer RJ, et al.
The findings suggest that, because virus stability is sufficient to support environmental MPXV transmission in healthcare settings, exposure and dose-response will be limiting factors for those transmission routes
Cheng L, Dhiyebi H, Varia M, Atanas K, Srikanthan N, Hayat S, et al..
At the peak of the Omicron BA.2 outbreak in April 2022, reported COVID-19 cases were underestimated 19-fold because of changes in clinical testing.
Morfino RC, Bart SM, Franklin A, et al.
Summary from publication: During August 1–September 9, 2022, the biotech company Ginkgo Bioworks, in collaboration with CDC, evaluated the feasibility of SARS-CoV-2 variant detection in aircraft wastewater from incoming international flights.
Ryerson AB, Lang D, Alazawi MA, et al.
